These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 19596407

  • 1. Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica.
    Branger CG, Torres-Escobar A, Sun W, Perry R, Fetherston J, Roland KL, Curtiss R.
    Vaccine; 2009 Aug 27; 27(39):5363-70. PubMed ID: 19596407
    [Abstract] [Full Text] [Related]

  • 2. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
    Branger CG, Fetherston JD, Perry RD, Curtiss R.
    Adv Exp Med Biol; 2007 Aug 27; 603():387-99. PubMed ID: 17966435
    [Abstract] [Full Text] [Related]

  • 3. Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis.
    Gupta A, Narayan B, Kumar S, Verma SK.
    Front Immunol; 2020 Aug 27; 11():988. PubMed ID: 32595634
    [Abstract] [Full Text] [Related]

  • 4. Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model.
    Daniel C, Dewitte A, Poiret S, Marceau M, Simonet M, Marceau L, Descombes G, Boutillier D, Bennaceur N, Bontemps-Gallo S, Lemaître N, Sebbane F.
    Front Immunol; 2019 Aug 27; 10():1830. PubMed ID: 31428104
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice.
    Torres-Escobar A, Juárez-Rodríguez MD, Gunn BM, Branger CG, Tinge SA, Curtiss R.
    Infect Immun; 2010 Jun 27; 78(6):2529-43. PubMed ID: 20308296
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C, Titecat M, Poiret S, Cayet D, Boutillier D, Simonet M, Sirard JC, Lemaître N, Sebbane F.
    Vaccine; 2016 Nov 11; 34(47):5762-5767. PubMed ID: 27742220
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
    Roggenkamp A, Geiger AM, Leitritz L, Kessler A, Heesemann J.
    Infect Immun; 1997 Feb 11; 65(2):446-51. PubMed ID: 9009295
    [Abstract] [Full Text] [Related]

  • 16. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
    Galen JE, Wang JY, Carrasco JA, Lloyd SA, Mellado-Sanchez G, Diaz-McNair J, Franco O, Buskirk AD, Nataro JP, Pasetti MF.
    Infect Immun; 2015 Jan 11; 83(1):161-72. PubMed ID: 25332120
    [Abstract] [Full Text] [Related]

  • 17. Preparation of monoclonal antibody to V antigen from Yersinia pestis.
    Sato K, Nakajima R, Hara F, Une T, Osada Y.
    Contrib Microbiol Immunol; 1991 Jan 11; 12():225-9. PubMed ID: 1935094
    [No Abstract] [Full Text] [Related]

  • 18. Oral vaccination with live attenuated Yersinia pseudotuberculosis strains delivering a FliC180-LcrV fusion antigen confers protection against pulmonary Y. Pestis infection.
    Singh AK, Wang X, Sun W.
    Vaccine; 2020 May 06; 38(21):3720-3728. PubMed ID: 32278523
    [Abstract] [Full Text] [Related]

  • 19. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
    Zhang Y, Bliska JB.
    Infect Immun; 2010 May 06; 78(5):2329-41. PubMed ID: 20231414
    [Abstract] [Full Text] [Related]

  • 20. Roles of V antigen in promoting virulence in Yersiniae.
    Une T, Nakajima R, Brubaker RR.
    Contrib Microbiol Immunol; 1987 May 06; 9():179-85. PubMed ID: 3665496
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.